ICON Public Limited Company ICLR

NASDAQ | Clinical research services

General analysis — not personal advice.

Signal

NEUTRAL

Sentiment

6/10

Risk

8/10

While the investigation conclusion reduces one overhang and the market has repriced accordingly, confirmed material weaknesses, pending restatements, and Nasdaq compliance/reporting risk warrant a reassessment before moving to a clear add/reduce stance.

This picture changes. Follow ICON Public Limited Company free — email when the signal or risk changes + a Sunday weekly brief.

Follow ICON Public Limited Company free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Price & valuation

Last close

USD 166

2026-08-10

1 week

+1.6 %

3 months

+41.5 %

12 months

-1.8 %

From 52w high

-18.2 %

From 52w low

+107.4 %

Market sentiment

Sentiment has improved from a crisis/non-reliance narrative to cautious relief after the investigation conclusion and new guidance, but remains mixed due to restatement needs, control weaknesses, and reporting/compliance uncertainty.

Why NEUTRAL?

Wait/review: hold only if you can tolerate elevated governance and reporting risk; consider delaying new buys until restatement and internal-control remediation visibility improves.

We're already tracking ICON Public Limited Company — here are the latest events we've registered

Recent News

On May 27, 2026, ICON released Q4/FY 2025 results and disclosed the outcome of the Audit Committee investigation: clinical services revenue was overstated across Q3 2023–Q4 2024, and the company identified material weaknesses in internal control over financial reporting with a remediation plan underway. ICON also issued 2026 guidance (revenue ~$7.85–$8.15B and adjusted EPS ~$10–$11), received a Nasdaq notice related to a late 20-F filing, and the stock reacted positively after the investigation concluded. ICON also expanded US early-phase capacity (new San Antonio CRU with satellite sites).

Catalysts

Restatements for 2023–2024

Create free account — follow 3 companies

What Firelda Watch includes for ICON Public Limited Company

Add the company to your watchlist and get all of this automatically.

Free: 3 companies on your watchlist
Change history and monitoring for every company you follow
Sunday weekly brief — AI roundup of the week's news
Watch/Ultra: same-day email when something material happens

Want to see what a finished analysis looks like?

View a sample analysis

This is a real Firelda analysis. Your analysis of ICON Public Limited Company will be delivered in the same format.

Own ICON Public Limited Company? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.

Follow 3 companies free